Trump signed a preliminary agreement with Iran yesterday to end the war and open the Strait of Hormuz. And, the president's approval rating has hit a record low, according to a new NPR poll.
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories. Why it matters: The early-stage clinical trial will signal whether "cellular reprogramming" can be performed safely in humans, a prerequisite for any future claim that a treatment can slow or even reverse biological aging. The big picture: Attempts to prolong the human lifespan can refer to anything from better diet and exercise to the infusion of blood plasma from young donors. - The former is validated by decades of science; the latter has merited two warnings from the Food and Drug Administration that said such treatments lack any evidence of clinical benefit. …
Trump has increasingly treated the stock market as a real-time referendum on his presidency, citing market gains as justification for many consequential decisions.
Often considered thrill seekers looking for the next adrenaline hit, participants say they’re actually drawn to control and a sense of time slowing down.
Lacy Reynolds was waiting to catch the next flight when the aircraft crashed in Butler, Mo., killing 11 passengers and a pilot. She wasn’t sure she could keep skydiving.
The Guardrails Alliance, which has raised $5 million, is positioning itself as a populist effort that will take on the pro-A.I. interests trying to influence this year’s elections.